Back to results
US 2022/0175936 A1Published application
Antiviral prodrugs and nanoformulations thereof
AssigneeBoard of Regents of the University of Nebraska
InventorsHoward Gendelman, Benson Edagwa
Life of this patent
Estimating the term…
Abstract
The present invention provides prodrugs and methods of use thereof.
Claims22
1-36. (canceled)
A compound, or a pharmaceutically acceptable salt thereof, comprising a first integrase inhibitor and a second integrase inhibitor, wherein said first and second integrase inhibitors are covalently attached by a linker.
A compound, or a pharmaceutically acceptable salt thereof, comprising an integrase inhibitor conjugated to an amino acid fatty ester, wherein the amino acid fatty ester comprises an aliphatic group.
Dependencies are inferred from the claim text.